Is a lack of female participants skewing heart disease trial results?
Heart disease is one of the leading causes of death in men and women, but women are commonly underrepresented in...
Trending:
-
![World Malaria Report 2018]()
WHO World Malaria Report 2018: stalling progress, but implementing new approach
-
![peanut allergy]()
Aimmune publishes phase III data for peanut allergy drug
-
![]()
How blockchain-backed secure document transfer could replace paper
-
![Imfinzi failure]()
AstraZeneca’s Imfinzi alone and in combination fails in Stage IV lung cancer trial
-
![]()
Unreal Engine: from gaming to ground-breaking cures
-
![NHS staff shortage]()
UK health service may face shortage of 350,000 staff by 2030
Expert commentary & analysis from GlobalData
The future of Pfizer’s $5bn Lyrica brand is in jeopardy
Krystal Biotech recruits more patients for Phase I/II topical gene therapy trial
Is the GAIN Act stimulating antibiotic R&D?
Jefferies Healthcare Conference 2018: SOBI bets on the haemophilia market
Most Read
Company releases
See Innovative Micronisation and Containment Solutions at CPhI
FPS has announced it will be showcasing its innovations on micronisation and containment at CphI India.
Webinar: Conquering the Chaos
IKA Wins German Design Award for easy-to-clean disperser
The high-performance IKA T 25 easy-to-clean disperser is one of the first of its kind for use in research, product...
Medelpharm Launches New Benchtop Tableting Instrument
Cutting through the Industry 4.0 Paradigm Webinar
Zenith Technology has announced that its global director David Staunton will be hosting a webinar on...
Company whitepapers
Biopharmaceuticals and Liposomal Formulations
Polymun ScientificInnovative High Containment Pharmaceutical Sieving System from Russell Finex
Russell FinexThe Nymi™ Band
Nymi™Getting Acquainted with the XRF Theory
Malvern PanalyticalDose Delivery Methodology by Sterigenics’ CompactCell
SterigenicsThe Future of the Pharmaceutical Industry
NSF International, Pharma BiotechIKA Case Study: Developing Sustainable Textiles
IKA-Werke GmbH & CoCompany A-Z
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.
Projects
Astellas Institute for Regenerative Medicine Relocation
Japanese pharmaceutical company Astellas Pharma has announced plans to relocate its wholly-owned US subsidiary Astellas Institute for Regenerative Medicine (AIRM) in December 2017.
Medicago’s Vaccine Production Facility, Quebec, Canada
GRAM’s Pharmaceutical Manufacturing Facility, Michigan, US
Boehringer Ingelheim’s Biopharmaceutical Production Facility in Vienna, Austria
Lonza’s Ibex Biomanufacturing Complex in Visp, Switzerland
Clinical Trials
Aimmune publishes phase III data for peanut allergy drug
Aimmune has published the data from its phase III PALISADE clinical trial into AR101, a biologic immunotherapy indicated for desensitisation of patients with peanut allergies...
Genomic profiling offers hope for rare cancer treatments
Foamix publishes top line phase III results for rosacea drug
Lilly’s Trulicity shows superiority in reducing CV events in type 2 diabetes
Nurocor partners with Intilaris to improve clinical trial planning process
Drug Development
Cambrex signs $252m agreement to acquire Avista Pharma
Generic active pharmaceutical ingredients (APIs) manufacturer Cambrex has signed a $252m definitive agreement to purchase Avista Pharma Solutions (Avista).
Roivant and iNtRON sign licensing deal for SAL200
Boehringer partners with Epizyme to develop new cancer therapies
Biogen and Amicus win UK Prix Galien awards for rare disease medicines
AstraZeneca’s Imfinzi alone and in combination fails in Stage IV lung cancer trial
Market Data
M&As this week: Nestle Health, InvaGen, Takeda
Nestle Health has acquired a 19% stake in Aimmune Therapeutics for $98m.
Deals this week: Swedish Orphan Biovitrum, Vectura
UK health service may face shortage of 350,000 staff by 2030
Sandoz recalls one batch of hypertension drug over impurity
M&As this week: Alexion Pharmaceutical, OvaScience
Technology
Elsevier introduces cloud-based platform for life sciences companies
Analytics firm Elsevier has introduced a new Cloud-based platform to support life sciences companies in addressing the changes occurring in modern research and development (R&D).
Otsuka expands digital medicines alliance with Proteus Digital
Sandoz launches second Healthcare Access Challenge
Hong Kong researchers create tiny soft robot for drug delivery
Innovate UK funds AI drug discovery platform